.Zevra Therapies' uncommon disease medicine seems to become on the road to approval this loss after ...
.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene treatment failing has blown a $230 million ho...
.After much more than twenty years of focus on neurodegenerative conditions, Swiss biotech a/c Invul...
.GSK has broken up a phase 2 individual papillomavirus (HPV) vaccination coming from its own pipe af...
.OS Therapies will definitely list on the NYSE American supply substitution today via a $6.4 million...
.ALX Oncology's stage 2 stomach cancer cells response price has weakened. After viewing its CD47 blo...
.One More of Ionis Pharmaceuticals' essential midphase readouts has disappointed requirements, trigg...
.While Biogen's pharma peers are looking for late-stage resources along with little danger, CEO Chri...
.Instil Bio has been actually a biotech trying to find a pipe after it junked its lead assets over t...
.Biogen has restored legal rights to an early Alzheimer's disease plan to Denali Therapeutics, going...